Literature DB >> 2925710

The surgical margin in soft-tissue sarcoma.

R S Bell1, B O'Sullivan, F F Liu, J Powell, F Langer, V L Fornasier, B Cummings, P N Miceli, N Hawkins, I Quirt.   

Abstract

In a retrospective review of 231 patients who were referred to Princess Margaret Hospital because of a soft-tissue sarcoma in an extremity, 100 patients were identified who had no metastases when they were first seen and who had been treated by local resection and adjuvant radiation therapy. Complete data were collected for each patient for the following variables: age; sex; location of the tumor and its size, grade, depth, and compartmental status; chemotherapy; and dose of radiation. The surgical margins were characterized as positive or negative for histological evidence of disease on the basis of an independent review of the pathological and operative reports by a surgeon and a radiation oncologist who were experienced in the management of sarcoma. Cox multivariate analysis was used to determine which of these variables contributed to local recurrence and evidence of systemic disease. Adequacy of the margin of resection was the only variable that was associated with local relapse (p = 0.0004). The size of the tumor (p = 0.0008) was the major determinant of the risk of systemic disease.

Entities:  

Mesh:

Year:  1989        PMID: 2925710

Source DB:  PubMed          Journal:  J Bone Joint Surg Am        ISSN: 0021-9355            Impact factor:   5.284


  25 in total

1.  Factors influencing complete tumor excision of mast cell tumors and soft tissue sarcomas: a retrospective study in 100 dogs.

Authors:  Beatriz Monteiro; Sarah Boston; Gabrielle Monteith
Journal:  Can Vet J       Date:  2011-11       Impact factor: 1.008

2.  Limb salvage in malignant tumors.

Authors:  Hans-Ulrich Steinau; Adrien Daigeler; Stefan Langer; Lars Steinsträsser; Jörg Hauser; Ole Goertz; Markus Lehnhardt
Journal:  Semin Plast Surg       Date:  2010-02       Impact factor: 2.314

3.  [Surgical margins in soft tissue sarcoma of the extremities].

Authors:  H-U Steinau; L Steinsträsser; S Langer; I Stricker; O Goertz
Journal:  Pathologe       Date:  2011-02       Impact factor: 1.011

4.  Factors predicting local recurrence, metastasis, and survival in pediatric soft tissue sarcoma in extremities.

Authors:  Chigusa Sawamura; Dempsey S Springfield; Karen J Marcus; Antonio R Perez-Atayde; Mark C Gebhardt
Journal:  Clin Orthop Relat Res       Date:  2010-11       Impact factor: 4.176

5.  What are risk factors for local recurrence of deep high-grade soft-tissue sarcomas?

Authors:  Chigusa Sawamura; Seiichi Matsumoto; Takashi Shimoji; Taisuke Tanizawa; Keisuke Ae
Journal:  Clin Orthop Relat Res       Date:  2012-03       Impact factor: 4.176

6.  Outcomes in patients with popliteal sarcomas.

Authors:  Robert E Turcotte; Marco Ferrone; Marc H Isler; Cynthia Wong
Journal:  Can J Surg       Date:  2009-02       Impact factor: 2.089

7.  The Width of the Surgical Margin Does Not Influence Outcomes in Extremity and Truncal Soft Tissue Sarcoma Treated With Radiotherapy.

Authors:  Rima Ahmad; Alex Jacobson; Francis Hornicek; Alex B Haynes; Edwin Choy; Gregory Cote; G Petur Nielsen; Yen-Lin Chen; Thomas F DeLaney; John T Mullen
Journal:  Oncologist       Date:  2016-07-20

8.  Adult soft tissue sarcoma local recurrence after adjuvant treatment without resection of core needle biopsy tract.

Authors:  Odion Binitie; Shawn Tejiram; Sheila Conway; David Cheong; H Thomas Temple; G Douglas Letson
Journal:  Clin Orthop Relat Res       Date:  2013-03       Impact factor: 4.176

9.  Uterine leiomyosarcoma management, outcome, and associated molecular biomarkers: a single institution's experience.

Authors:  Kristelle Lusby; Kari Brewer Savannah; Elizabeth G Demicco; Yiqun Zhang; Markus Ph Ghadimi; Eric D Young; Chiara Colombo; Ryan Lam; Tugce E Dogan; Jason L Hornick; Alexander J Lazar; Kelly K Hunt; Matthew L Anderson; Chad J Creighton; Dina Lev; Raphael E Pollock
Journal:  Ann Surg Oncol       Date:  2013-01-20       Impact factor: 5.344

10.  Surgical management for malignant tumors of the thumb.

Authors:  Mark E Puhaindran; Corey P Rothrock; Edward A Athanasian
Journal:  Hand (N Y)       Date:  2011-07-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.